View in EDS

Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.

Saved in:
Bibliographic Details
Title: Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Authors: Harter, P.1,2,3 (AUTHOR), Marth, C.1,4,5 (AUTHOR), Mouret-Reynier, M.-A.6,7 (AUTHOR), Cropet, C.8 (AUTHOR), Lorusso, D.9,10,11 (AUTHOR), Guerra-Alía, E.M.12,13 (AUTHOR), Matsumoto, T.14,15 (AUTHOR), Vergote, I.16,17 (AUTHOR), Colombo, N.18,19 (AUTHOR), Mäenpää, J.20,21 (AUTHOR), Lebreton, C.7,22 (AUTHOR), de Gregorio, N.3,23 (AUTHOR), Mosconi, A.M.11,24 (AUTHOR), Rubio-Pérez, M.J.13,25 (AUTHOR), Bourgeois, H.7,26 (AUTHOR), Fasching, P.A.3,27 (AUTHOR), Cecere, S.C.11,28 (AUTHOR), Hardy-Bessard, A.-C.7,29 (AUTHOR), Denschlag, D.3,30 (AUTHOR), de Percin, S.7,31 (AUTHOR)
Source: Annals of Oncology. Feb2025, Vol. 36 Issue 2, p185-196. 12p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.10.828